These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

240 related items for PubMed ID: 12667408

  • 1. Efficacy of recombinant tissue-type plasminogen activator thrombolysis and primary coronary stenting after acute myocardial infarction.
    Chen B, Wang W, Zhao H, Hu D, Xu C, Zhao M, Lu M, Liu J, Wu C.
    Chin Med J (Engl); 2003 Jan; 116(1):142-4. PubMed ID: 12667408
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Primary intracoronary stenting in comparison with intravenous rt-PA thrombolysis plus rescue intracoronary intervention in patients with acute myocardial infarction.
    Zhang D, Cai X, Zhang R, Zhang J, Shen W.
    Chin Med J (Engl); 2002 Feb; 115(2):163-5. PubMed ID: 11940322
    [Abstract] [Full Text] [Related]

  • 4. [Usefulness of combination therapy of hybrid thrombolysis followed by back-up percutaneous transluminal coronary angioplasty in patients with acute myocardial infarction].
    Mukawa H, Sone T, Tsuboi H, Kondo J, Kosokabe T, Uesugi M, Imai H.
    J Cardiol; 2001 Apr; 37(4):181-9. PubMed ID: 11337927
    [Abstract] [Full Text] [Related]

  • 5. [The safety and efficacy of systemic salvage thrombolysis in acute myocardial infarct].
    Sarullo FM, Schicchi R, Schirò M, Americo L, Bonnì G, Faraone N, Di Pasquale P, Castello A, Mauri F.
    Ital Heart J Suppl; 2000 Jan; 1(1):81-7. PubMed ID: 10832123
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. [Efficacy of low-dose mutant tissue-type plasminogen activator followed by planned rescue percutaneous transluminal coronary angioplasty as reperfusion therapy for acute myocardial infarction].
    Tsukahara K, Kimura K, Usui T, Okuda J, Kitamura Y, Kosuge M, Sano T, Tohyama S, Nemoto T, Yamanaka O, Yoshii Y, Tochikubo O, Umemura S.
    J Cardiol; 2001 Mar; 37(3):143-50. PubMed ID: 11281054
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Primary angioplasty with routine stenting compared with thrombolytic therapy in elderly patients with acute myocardial infarction.
    Goldenberg I, Matetzky S, Halkin A, Roth A, Di Segni E, Freimark D, Elian D, Agranat O, Har Zahav Y, Guetta V, Hod H.
    Am Heart J; 2003 May; 145(5):862-7. PubMed ID: 12766745
    [Abstract] [Full Text] [Related]

  • 11. [Early intravenous thrombolysis with recombinant tissue plasminogen activator for acute cerebral infarction].
    Wang SY, Wang XL, Zeng H, Zuo Y, Hu N, Li XY, Huang F, Yu HL, Wang HY.
    Zhongguo Wei Zhong Bing Ji Jiu Yi Xue; 2003 Sep; 15(9):542-5. PubMed ID: 12971850
    [Abstract] [Full Text] [Related]

  • 12. [Comparative randomized study of the effectiveness of intravenous recombinant tissue-type plasminogen activator and intravenous streptokinase in patients with acute myocardial infarct. Report of the European Cooperative Study Group for Recombinant Tissue-Type Plasminogen Activator].
    Verstraete M, Bory M, Collen D, Erbel R, Lennane RJ, Mathey D, Michels HR, Schartl M, Uebis R, Bernard R.
    Klin Wochenschr; 1988 Sep; 66 Suppl 12():77-85. PubMed ID: 3126348
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. [Usefulness and safety of intravenous thrombolytic therapy for elderly patients with acute myocardial infarction: relationship with cardiac rupture].
    Sakai M, Imai T, Kuboki K, Maeda S, Ueda S, Kuwajima I, Ohkawa S, Matsushita S.
    J Cardiol; 1999 Mar; 33(3):153-61. PubMed ID: 10225195
    [Abstract] [Full Text] [Related]

  • 15. The effect of preinfarction angina on clinical reperfusion time in patients with acute myocardial infarction receiving successful thrombolytic therapy.
    Evrengul H, Celek T, Tanriverdi H, Kaftan A, Dursunoglu D, Kilic M.
    Can J Cardiol; 2005 Sep; 21(11):915-20. PubMed ID: 16239974
    [Abstract] [Full Text] [Related]

  • 16. [Platelet activation in the early phases of acute myocardial infarction].
    Salvioni A, Giraldi F, Assanelli E, Lauri G, Grazi M, Pardea S, Marenzi G.
    Cardiologia; 1998 Aug; 43(8):825-32. PubMed ID: 9808873
    [Abstract] [Full Text] [Related]

  • 17. Influence of different start time of urokinase therapy after acute myocardial infarction efficacy of thrombolysis. The Collaborative Research Group on Thrombolysis.
    Chin Med J (Engl); 1997 Jan; 110(1):47-9. PubMed ID: 9594321
    [Abstract] [Full Text] [Related]

  • 18. [Intravenous infusion of recombinant tissue-type plasminogen activator (rt-PA) and urokinase in acute myocardial infarct: intermediate results of the G.A.U.S. study (German Activator Urokinase Study)].
    Neuhaus KL, Tebbe U, Gottwik M, Weber MA, Feuerer W, Niederer W, Haerer W, Praetorius F, Grosser KD, Huhmann W.
    Klin Wochenschr; 1988 Jan; 66 Suppl 12():102-8. PubMed ID: 3126339
    [Abstract] [Full Text] [Related]

  • 19. Impact of metabolic syndrome on coronary patency after thrombolytic therapy for acute myocardial infarction.
    Yasar AS, Bilen E, Bilge M, Arslantas U, Karakas F.
    Coron Artery Dis; 2009 Sep; 20(6):387-91. PubMed ID: 19696662
    [Abstract] [Full Text] [Related]

  • 20. Beneficial effects of diltiazem during myocardial reperfusion: a randomized trial in acute myocardial infarction.
    Pizzetti G, Mailhac A, Li Volsi L, Di Marco F, Lu C, Margonato A, Chierchia SL.
    Ital Heart J; 2001 Oct; 2(10):757-65. PubMed ID: 11721720
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.